Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Angiogenic Switch as Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer

NCT02075086 is registered in ClinicalTrials.gov with Grupo Hospital de Madrid as lead sponsor.

NCT NCT02075086
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02075086 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Angiogenic Switch as Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer
Lead sponsor
Grupo Hospital de Madrid
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2011
Completion date
May 31, 2015
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer